Cargando…

What can we expect from first-generation COVID-19 vaccines?

Detalles Bibliográficos
Autores principales:	Peiris, Malik, Leung, Gabriel M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505651/ https://www.ncbi.nlm.nih.gov/pubmed/32971042 http://dx.doi.org/10.1016/S0140-6736(20)31976-0

Ejemplares similares

Offline: COVID-19—what we can expect to come
por: Horton, Richard
Publicado: (2020)

The COVID-19 pandemic in the USA: what might we expect?
por: Chowell, Gerardo, et al.
Publicado: (2020)

COVID-19 vaccine: what are we doing and what should we do?
por: Candelli, Marcello
Publicado: (2022)

COVID-19 and strongyloidiasis: what to expect from this coinfection?
por: Pereira, Carolina Victoria Marcitelli, et al.
Publicado: (2021)

COVID-19 vaccination challenge: what have we learned from the Brazilian process?
por: Lotta, Gabriela, et al.
Publicado: (2022)

SARS legacy: outbreak reporting is expected and respected
por: Heymann, David L, et al.
Publicado: (2013)

Expecting the unexpected with COVID-19 vaccines
por: Bar-Zeev, Naor, et al.
Publicado: (2021)

COVID-19 and cancer: do we really know what we think we know?
por: Robinson, Andrew G., et al.
Publicado: (2020)

ECMO for severe ARDS associated with COVID-19: now we know we can, but should we?
por: Shekar, Kiran, et al.
Publicado: (2020)

Cancer and COVID-19: what do we really know?
por: Poortmans, Philip M, et al.
Publicado: (2020)

Pregnancy in sickle cell disease – do we know what to expect?()
por: Fertrin, Kleber Yotsumoto
Publicado: (2014)

Offline: COVID-19—what have we learned so far?
por: Horton, Richard
Publicado: (2020)

Vaccination against COVID-19: Expectations and concerns of patients with autoimmune and rheumatic diseases
por: Felten, Renaud, et al.
Publicado: (2021)

What can we learn from cases of internal mammary artery damage in coronary artery bypass graft?
por: Chen, Mi, et al.
Publicado: (2019)

Preventing post-partum haemorrhage at home during COVID-19: what are we waiting for?
por: Hobday, Karen, et al.
Publicado: (2021)

Canada 2010: what should global health expect?
por: Horton, Richard
Publicado: (2009)

Can ketogenic dietary interventions slow disease progression in ADPKD: what we know and what we don't
por: Ong, Albert C M, et al.
Publicado: (2022)

Modelling Covid-19 under uncertainty: what can we expect?
por: Wang, Meimei, et al.
Publicado: (2020)

Lung cancer in the era of COVID-19: what can we expect?
por: Araujo-Filho, Jose de Arimateia Batista, et al.
Publicado: (2020)

Kidney replacement therapy patients with COVID-19 in the vaccine era: what do we need to know?
por: Vehbi, Sezan, et al.
Publicado: (2022)

COVID-19 vaccines for children younger than 12 years: are we ready?
por: Zou, Xiaohui, et al.
Publicado: (2021)

Can we migrate COVID-19 spreading risk?
por: Chen, Qingyan
Publicado: (2020)

Next-generation COVID-19 vaccines: here come the proteins
por: Blakney, Anna K, et al.
Publicado: (2021)

Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?
por: Torres, A., et al.
Publicado: (2014)

Reversal Agents: What We Have and What We Can Expect
por: Ruff, Christian T.
Publicado: (2018)

The role of the patient in patient safety: What can we learn from healthcare’s history?
por: Leistikow, Ian, et al.
Publicado: (2018)

Life on Mars, can we detect it?
por: Stoker, Carol R.
Publicado: (2023)

Targeting hyperinflammation in infection: can we harness the COVID-19 therapeutics momentum to end the dengue drugs drought?
por: McBride, Angela, et al.
Publicado: (2021)

Erratum to: Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?
por: Torres, A., et al.
Publicado: (2014)

COVID-19 and other adult vaccines can drive global disease prevention
por: Agus, David B, et al.
Publicado: (2023)

COVID-19 vaccines: breaking record times to first-in-human trials
por: Kim, Young Chan, et al.
Publicado: (2020)

Impact of methotrexate on first-dose COVID-19 mRNA vaccination
por: Connolly, Caoilfhionn M, et al.
Publicado: (2021)

How can we get sober from the influence of the alcohol industry?
por: Monteiro, Maristela G, et al.
Publicado: (2022)

Aberrant cytokine milieu and signaling affect immune cell phenotypes and functions in tuberculosis pathology: What can we learn from this phenomenon for application to inflammatory syndromes?
por: Adankwah, Ernest, et al.
Publicado: (2021)

SARS-CoV-2 Vaccination: What Can We Expect Now?
por: Meurens, François, et al.
Publicado: (2022)

What can psychiatrists learn from SARS and MERS outbreaks?
por: Sommer, Iris E, et al.
Publicado: (2020)

Next-generation carrier screening: are we ready?
por: Prior, Thomas W
Publicado: (2014)

Neuropsychiatric Consequences of COVID-19: What Do We Know So Far?
por: Machado, Sergio, et al.
Publicado: (2022)

What could fair allocation of an efficacious COVID-19 vaccine look like in South Africa?
por: Moodley, Keymanthri, et al.
Publicado: (2021)

What a second booster dose of mRNA COVID-19 vaccines tells us
por: Loubet, Paul, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_iv0ud6p1fio242a2o0b7fumd53